NAP
BIIB icon

New Amsterdam Partners’s Biogen BIIB Stock Holding History

New Amsterdam Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,863
Closed -$593K – 115
2017
Q4 		$593K Buy
1,863
+392
+27% +$126K 0.12% 93
2017
Q3 		$461K Hold
1,471
– – 0.1% 104
2017
Q2 		$399K Buy
1,471
+11
+0.8% +$2.91K 0.08% 107
2017
Q1 		$399K Sell
1,460
-259
-15% -$73.2K 0.09% 110
2016
Q4 		$487K Sell
1,719
-15
-0.9% -$4.45K 0.11% 108
2016
Q3 		$543K Sell
1,734
-37
-2% -$11K 0.12% 101
2016
Q2 		$428K Sell
1,771
-305
-15% -$80.4K 0.1% 104
2016
Q1 		$540K Sell
2,076
-192
-8% -$50.7K 0.06% 102
2015
Q4 		$695K Sell
2,268
-677
-23% -$195K 0.07% 101
2015
Q3 		$859K Buy
2,945
+496
+20% +$164K 0.09% 94
2015
Q2 		$989K Sell
2,449
-7,510
-75% -$3.01M 0.09% 88
2015
Q1 		$4.21M Buy
9,959
+18
+0.2% +$7.09K 0.34% 68
2014
Q4 		$3.37M Hold
9,941
– – 0.29% 88
2014
Q3 		$3.29M Sell
9,941
-7
-0.1% -$2.31K 0.22% 85
2014
Q2 		$3.14M Buy
+9,948
New +$2.99M 0.2% 88

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

New Amsterdam Partners's BIIB Position: Q1 2018 in Review

New Amsterdam Partners sold out of Biogen (BIIB) in Q1 2018, closing a stake of 1,863 shares — an estimated $593K sold.

New Amsterdam Partners first reported a position in BIIB in Q2 2014 and held it in 15 quarters. The position peaked at $4.21M in Q1 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • New Amsterdam Partners reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • New Amsterdam Partners sold 1,863 Biogen shares in Q1 2018, an estimated $593K.
  • New Amsterdam Partners first reported a position in Biogen in Q2 2014 and held it in 15 quarters.
  • New Amsterdam Partners's Biogen position peaked at $4.21M in Q1 2015.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on New Amsterdam Partners's 13F filing for Q1 2018, filed 7 May 2018.